Continuous Subcutaneous Foslevodopa/Foscarbidopa in Advanced Parkinson's Disease: Results From a 12-Month Phase 3 Study

J Aldred, A Amelin, A Antonini, B Bergmans, F Bergquist, M Bouchard, K Budur, C Carroll, K Chaudhuri, S Criswell, E Danielsen, EF Alvarez, F Gandor, J Jia, T Kimber, H Mochizuki, W Robieson, A Spiegel, D Standaert, S TalapalaM Facheris, V Fung

Research output: Contribution to conferenceConference paper (not formally published)peer-review

Original languageEnglish
DOIs
Publication statusPublished - Jul 2022

Cite this